Cargando…
Functional display of heterotetrameric human protein kinase CK2 on Escherichia coli: a novel tool for drug discovery
BACKGROUND: Human protein kinase CK2 represents a novel therapeutic target for neoplastic diseases. Inhibitors are in need to explore the druggability and the therapeutic options of this enzyme. A bottleneck in the search for new inhibitors is the availability of the target for testing. Therefore an...
Autores principales: | Gratz, Andreas, Bollacke, Andre, Stephan, Sara, Nienberg, Christian, Le Borgne, Marc, Götz, Claudia, Jose, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451881/ https://www.ncbi.nlm.nih.gov/pubmed/26036951 http://dx.doi.org/10.1186/s12934-015-0263-z |
Ejemplares similares
-
Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening
por: Nienberg, Christian, et al.
Publicado: (2017) -
Site-Specific Labeling of Protein Kinase CK2: Combining Surface Display and Click Chemistry for Drug Discovery Applications †
por: Nienberg, Christian, et al.
Publicado: (2016) -
A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors
por: Schnitzler, Alexander, et al.
Publicado: (2018) -
Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7
por: Nacereddine, Abdelhamid, et al.
Publicado: (2018) -
Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2
por: Alchab, Faten, et al.
Publicado: (2015)